https://academic.oup.com/ajcp/advance-article-abstract/doi/10.1093/ajcp/aqz030/5461358?redirectedFrom=fulltext

Comment; This begets the question; is the incidence increasing or are we just recognizing more of what’s been present all along…

Elizabeth Lee-Lewandrowski, PhD, MPHZhen Chen, MSJohn Branda, MDJason Baron, MDHarvey W Kaufman, MDAmerican Journal of Clinical Pathology, aqz030, https://doi.org/10.1093/ajcp/aqz030Published: 15 April 2019

search filter                                                              All  American Journal of Clinical Pathology                                                                   All  ASCP JournalsAll  Journals                                                         search input

ABSTRACT

Objectives

We evaluated trends in Lyme disease (LD) testing at a national reference laboratory.Methods

LD screening enzyme immunoassay and Western blot testing data performed at Quest Diagnostics during 2010 to 2016 were analyzed nationally and at the state level.Results

Overall, 593,800 (11.3%) results were positive of 5,255,636 tests. There was an increase in the rate of positivity over the last 2 years of the study and an increase in the number of positive tests in 2016. Positive tests were observed in all 50 states and the District of Columbia. New York had the most positive tests, whereas Connecticut had the highest positivity rate when normalized to state populations. Some states with historically low rates of LD (eg, Texas, Florida, and California) showed significant increases in testing and positivity rates over time.Conclusions

LD testing and positivity have increased in recent years, including in states not historically associated with the disease.

Elizabeth Lee-Lewandrowski, PhD, MPHZhen Chen, MSJohn Branda, MDJason Baron, MDHarvey W Kaufman, MDAmerican Journal of Clinical Pathology, aqz030, https://doi.org/10.1093/ajcp/aqz030Published: 15 April 2019